← Leaderboards
Qianqian Zhu
Roswell Park Cancer Institute Corp
$1,921,800
Attributed
$5,765,399
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,765,399 · 3
By mechanism
R01$3,120,296 · 1
U01$2,471,003 · 1
R03$174,100 · 1
Top collaborators
- Alyssa Ione Clay-Gilmour5 shared
- Theresa E Hahn5 shared
- Song Liu4 shared
- Hua Zhao4 shared
- Kara M Kelly2 shared
- Song Yao2 shared
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Theresa E Hahn$4,613,853
- Alyssa Ione Clay-Gilmour$1,711,362
- Hua Zhao$6,386,020
- Song Liu$6,652,425
- Robert Page Edwards$5,636,497
Others in their field
Other Emerging Leaders on “Cohort”
- Leonard Freedman · Leidos Biomedical Research, Inc.$70,225,348
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
- Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Scott Hensley · University Of Pennsylvania$47,346,110
- Susan M Landau · University Of California Berkeley$47,252,026
Research focus
CohortGenotypeSamplingGeneticGenome-WideResourcesPathway InteractionsEtiologyLifePolygenic Risk ScoreExome SequencingEuropeanVariantPredispositionPlayGenetic VariantGenome Wide Association StudyGenesValidationAffectExome10q21AntigensEthnic Origin
Grant awards (11)
Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor$952,237
U01 · FY2025 · CA
Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation$605,569
R01 · FY2025 · CA
Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation$593,753
R01 · FY2024 · CA
Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor$484,154
U01 · FY2024 · CA
Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor$522,328
U01 · FY2023 · CA
Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation$503,068
R01 · FY2023 · CA
Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor$512,284
U01 · FY2022 · CA
Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation$463,641
R01 · FY2022 · CA
Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation$954,265
R01 · FY2021 · CA
Genetic underpinnings of ethnic disparities in bone toxicities between Hispanic and non-Hispanic children treated for acute lymphoblastic leukemia$87,050
R03 · FY2019 · CA
Genetic underpinnings of ethnic disparities in bone toxicities between Hispanic and non-Hispanic children treated for acute lymphoblastic leukemia$87,050
R03 · FY2018 · CA